NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Condition:   Carcinoma, Squamous Cell of Head and Neck
Interventions:   Drug: NC-6004;   Drug: Cetuximab;   Drug: 5-FU
Sponsor:   NanoCarrier Co., Ltd.
Recruiting - verified April 2017

http://ift.tt/2o5ltYn